Skip links

After a new cancer drug is approved for adults, pediatric clinical research takes an average of 9.5 more years.
After a new cancer drug is approved for adults, pediatric clinical research takes an average of 9.5 more years.
In the past 25 YEARS, the FDA has initially approved only THREE DRUGS for a childhood cancer.
In the past 25 YEARS, the FDA has initially approved only THREE DRUGS for a childhood cancer.
Number of cancer drugs in the pipeline for adults: 900.  For kids: ALMOST NONE.
Number of cancer drugs in the pipeline for adults: 900. For kids: ALMOST NONE.

WHAT IF

we focused as much effort on solving cancer for children as we do on solving cancer for adults?

Advancing our mission

 

The Kids Act/RACE for Children Act

RACE FOR CHILDREN ACT

MORE »

The Creating Hope Act

CREATING HOPE ACT PEDIATRIC PRV reauthorized  MORE »

Compassionate Use Navigator

COMPASSIONATE USE NAVIGATOR

MORE »

Tissue Donation

TISSUE DONATION

MORE »

News

News

What you can do today

Donate

Your support makes our work possible. Please read about our work in 2016 End of Year Letter and donate today. Thank you!

Youth Lobby Days

Join us in Washington, D.C. to tell Congress what you think about pediatric cancer.  Sign-up here.

Share Your Story

Your story raises awareness about pediatric cancer. Please read stories of other kids.
Share your story here»

Recognition of our work

We  have created almost $1 billion in R&D incentives for pediatric rare disease drug development.